These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumors. Beavis PA; Divisekera U; Paget C; Chow MT; John LB; Devaud C; Dwyer K; Stagg J; Smyth MJ; Darcy PK Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14711-6. PubMed ID: 23964122 [TBL] [Abstract][Full Text] [Related]
5. CD73 plays a protective role in collagen-induced arthritis. Chrobak P; Charlebois R; Rejtar P; El Bikai R; Allard B; Stagg J J Immunol; 2015 Mar; 194(6):2487-92. PubMed ID: 25681339 [TBL] [Abstract][Full Text] [Related]
6. Anti-human CD73 monoclonal antibody inhibits metastasis formation in human breast cancer by inducing clustering and internalization of CD73 expressed on the surface of cancer cells. Terp MG; Olesen KA; Arnspang EC; Lund RR; Lagerholm BC; Ditzel HJ; Leth-Larsen R J Immunol; 2013 Oct; 191(8):4165-73. PubMed ID: 24043904 [TBL] [Abstract][Full Text] [Related]
7. Targeting CD73 enhances the antitumor activity of anti-PD-1 and anti-CTLA-4 mAbs. Allard B; Pommey S; Smyth MJ; Stagg J Clin Cancer Res; 2013 Oct; 19(20):5626-35. PubMed ID: 23983257 [TBL] [Abstract][Full Text] [Related]
8. Ecto-5'-nucleotidase/CD73 enhances endothelial barrier function and sprouting in blood but not lymphatic vasculature. Yegutkin GG; Auvinen K; Rantakari P; Hollmén M; Karikoski M; Grénman R; Elima K; Jalkanen S; Salmi M Eur J Immunol; 2015 Feb; 45(2):562-73. PubMed ID: 25402681 [TBL] [Abstract][Full Text] [Related]
9. CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice. Wang L; Fan J; Thompson LF; Zhang Y; Shin T; Curiel TJ; Zhang B J Clin Invest; 2011 Jun; 121(6):2371-82. PubMed ID: 21537079 [TBL] [Abstract][Full Text] [Related]
14. Allergen-induced airway hyperresponsiveness is absent in ecto-5'-nucleotidase (CD73)-deficient mice. Schreiber R; Castrop H; Kunzelmann K Pflugers Arch; 2008 Nov; 457(2):431-40. PubMed ID: 18607626 [TBL] [Abstract][Full Text] [Related]
15. In Vivo Immunological Effects of CD73 Deficiency. Adam T; Mathes A; Isayev O; Philippov PP; Werner J; Karakhanova S; Bazhin AV Cell Physiol Biochem; 2019; 52(5):1192-1202. PubMed ID: 31001959 [TBL] [Abstract][Full Text] [Related]
16. Extracellular purine metabolism and signaling of CD73-derived adenosine in murine Treg and Teff cells. Romio M; Reinbeck B; Bongardt S; Hüls S; Burghoff S; Schrader J Am J Physiol Cell Physiol; 2011 Aug; 301(2):C530-9. PubMed ID: 21593451 [TBL] [Abstract][Full Text] [Related]
17. CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression. Jin D; Fan J; Wang L; Thompson LF; Liu A; Daniel BJ; Shin T; Curiel TJ; Zhang B Cancer Res; 2010 Mar; 70(6):2245-55. PubMed ID: 20179192 [TBL] [Abstract][Full Text] [Related]
18. Specific blockade CD73 alters the "exhausted" phenotype of T cells in head and neck squamous cell carcinoma. Deng WW; Li YC; Ma SR; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ Int J Cancer; 2018 Sep; 143(6):1494-1504. PubMed ID: 29663369 [TBL] [Abstract][Full Text] [Related]
20. The volatile anesthetic isoflurane induces ecto-5'-nucleotidase (CD73) to protect against renal ischemia and reperfusion injury. Kim M; Ham A; Kim JY; Brown KM; D'Agati VD; Lee HT Kidney Int; 2013 Jul; 84(1):90-103. PubMed ID: 23423261 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]